Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients — Innovation Pharmaceuticals Inc. – #stocks chatter

0
258

Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients — Innovation Pharmaceuticals Inc.

http://www.ipharminc.com/press-release/2021/2/26/innovation-pharma-provides-study-details-for-ongoing-phase-2-clinical-trial-of-brilacidin-in-hospitalized-covid-19-patients

LEAVE A REPLY

Please enter your comment!
Please enter your name here

seventeen − thirteen =

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.